Literature DB >> 15030556

Treatment protocols for demodicosis: an evidence-based review.

Ralf S Mueller1.   

Abstract

Publications discussing the treatment of demodicosis in the dog and cat are reviewed. Based on the evidence in the literature, amitraz rinses at 0.025-0.06% every 7-14 days, and oral daily ivermectin at 300 micro g kg(-1), milbemycin at 2 mg kg(-1) and moxidectin at 400 micro g kg(-1), respectively, can all be recommended for the treatment of generalized canine demodicosis. Ivermectin and moxidectin should be initiated at lower doses and patients monitored for possible adverse effects during therapy. In cats, 2% lime sulfur dips and amitraz rinses at 0.0125-0.025% have been used successfully.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030556     DOI: 10.1111/j.1365-3164.2004.00344.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  18 in total

1.  Successful management of refractory cases of canine demodicosis with homeopathy medicine Graphitis.

Authors:  Rakesh Ranjan; Kirti Dua; Sujata Turkar; Harkirat Singh; L D Singla
Journal:  J Parasit Dis       Date:  2013-03-02

2.  The first case of Demodex gatoi in Austria, detected with fecal flotation.

Authors:  Katja Silbermayr; Anja Joachim; Barbara Litschauer; Lucia Panakova; Natalia Sastre; Lluis Ferrer; Christa Horvath-Ungerboeck
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

3.  Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.

Authors:  Feli M Walther; Mark J Allan; Rainer K A Roepke
Journal:  Parasit Vectors       Date:  2015-10-06       Impact factor: 3.876

4.  The main factors influencing canine demodicosis treatment outcome and determination of optimal therapy.

Authors:  Milica Arsenović; Lato Pezo; Nebojša Vasić; Rodoljub Ćirić; Milan Stefanović
Journal:  Parasitol Res       Date:  2015-05-28       Impact factor: 2.289

5.  Skin mites in mice (Mus musculus): high prevalence of Myobia sp. (Acari, Arachnida) in Robertsonian mice.

Authors:  Natalia Sastre; Oriol Calvete; Jessica Martínez-Vargas; Nuria Medarde; Joaquim Casellas; Laura Altet; Armand Sánchez; Olga Francino; Jacint Ventura
Journal:  Parasitol Res       Date:  2018-05-04       Impact factor: 2.289

6.  A systematic review of moxidectin as a treatment for parasitic infections in mammalian species.

Authors:  Andrea L Schraven; Hayley J Stannard; Julie M Old
Journal:  Parasitol Res       Date:  2021-02-22       Impact factor: 2.289

7.  Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.

Authors:  Josephus J Fourie; Petrus C Delport; Leon J Fourie; Josef Heine; Ivan G Horak; Klemens J Krieger
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

8.  Safety and efficacy of topical lime sulfur in mice infested with Myocoptes musculinus.

Authors:  Jennifer S Wood; Cynthia L Courtney; Karen A Lieber; Vanessa K Lee
Journal:  J Am Assoc Lab Anim Sci       Date:  2013       Impact factor: 1.232

9.  Ivermectin-compounded Feed Compared with Topical Moxidectin-Imidacloprid for Eradication of Demodex musculi in Laboratory Mice.

Authors:  Melissa A Nashat; Rodolfo J Ricart Arbona; Michelle L Lepherd; Sara F Santagostino; Robert S Livingston; Elyn R Riedel; Neil S Lipman
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-09-05       Impact factor: 1.232

10.  Demodex gatoi-associated contagious pruritic dermatosis in cats--a report from six households in Finland.

Authors:  Seppo A M Saari; Kirsi H Juuti; Joanna H Palojärvi; Kirsi M Väisänen; Riitta-Liisa Rajaniemi; Leena E Saijonmaa-Koulumies
Journal:  Acta Vet Scand       Date:  2009-10-20       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.